Macquarie Group LTD Crispr Therapeutics Ag Transaction History

Macquarie Group LTD

$87.4 Billion
Q1 2024

A detailed history of Macquarie Group LTD transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, Macquarie Group LTD holds 27,678 shares of CRSP stock, worth $1.49 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

27,678

Holding current value

$1.49 Million

% of portfolio

0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$60.67 - $89.12 $1.68 Million - $2.47 Million	27,678 New	27,678 $1.89 Million
Q1 2023 May 15, 2023	SELL	$41.0 - $56.12 $1.61 Million - $2.21 Million	-39,318 Reduced 98.44%	623 $28,000
Q4 2022 Feb 21, 2023	SELL	$39.19 - $65.67 $31.3 Million - $52.4 Million	-797,494 Reduced 95.23%	39,941 $1.62 Million
Q3 2022 Nov 14, 2022	BUY	$61.1 - $83.78 $45.7 Million - $62.6 Million	747,413 Added 830.26%	837,435 $54.8 Million
Q2 2022 Aug 15, 2022	BUY	$43.23 - $73.83 $3.81 Million - $6.5 Million	88,055 Added 4476.61%	90,022 $5.47 Million

Q4 2021 Feb 11, 2022	SELL	$70.09 - $111.29 $68.9 Million - $109 Million	-982,923 Reduced 99.8%	1,967 $149,000
Q3 2021 Nov 12, 2021	SELL	$110.2 - $156.64 $19.3 Million - $27.4 Million	-174,877 Reduced 15.08%	984,890 $110 Million
Q2 2021 Aug 13, 2021	BUY	$100.84 - $161.89 $117 Million - $187 Million	1,155,532 Added 27285.29%	1,159,767 $188 Million
Q1 2021 May 14, 2021	SELL	$110.72 - $210.04 $17.3 Million - $32.8 Million	-156,100 Reduced 97.36%	4,235 $516,000
Q4 2020 Feb 16, 2021	BUY	$79.67 - $173.23 $7.43 Million - $16.2 Million	93,291 Added 139.15%	160,335 $24.5 Million
Q3 2020 Nov 13, 2020	SELL	$78.5 - $100.64 $2.22 Million - $2.85 Million	-28,296 Reduced 29.68%	67,044 $5.61 Million
Q2 2020 Aug 11, 2020	BUY	$38.5 - $76.05 $3.67 Million - $7.25 Million	95,340 New	95,340 $7.01 Million
Q1 2018 May 11, 2018	SELL	$23.52 - $58.17 $14,112 - $34,902	-600 Closed	0 $0
Q4 2017 Feb 15, 2018	BUY	$16.95 - $23.48 $10,170 - $14,088	600	600 $14,000

Others Institutions Holding CRSP

# of Institutions

549

Shares Held

56.3M

Call Options Held

2.91M

Put Options Held

2.47M

View Full List

About CRISPR Therapeutics AG

Ticker CRSP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,009,296
Market Cap $4.21B
Description
CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....

More about CRSP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Macquarie Group LTD, based on Form 13F filings with the SEC.

News

Stay updated on Macquarie Group LTD with notifications on news.

Account

Macquarie Group LTD Crispr Therapeutics Ag Transaction History